Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 11
Phase 21

Trial Status

Recruiting1

Role Distribution

Principal Investigator1
PI Rate100%

Activity Timeline

Clinical Trials (1)

NCT07193134Phase 1/2Recruiting
GMEB-SASS: A Gene-Modified Skin Substitute for RDEB Treatment
Epidermolysis Bullosa Dystrophica, RecessiveRDEBRecessive Dystrophic Epidermolysis Bullosa
PrincipalinvestigatorStart date: 2026-01-07

Research Network

Collaboration Network

2 collaborators·1 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

The Hospital for Sick Children

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Lucie Germain, PhD

CHU de Québec-Université Laval

Moderately Similar
1 trials

Shared therapeutic areas:

Hallopeau-Siemens DiseaseRDEBRecessive Dystrophic Epidermolysis Bullosa

Worked with same sponsors:

CHU de Quebec-Universite Laval
Collaborated on 1 trial
Similarity Score34%

Sarah Abdelwahab, MD

Abeona Therapeutics, Inc

Related
2 trials

Shared therapeutic areas:

RDEBRecessive Dystrophic Epidermolysis Bullosa
Similarity Score20%

Angela Iheanacho, MS

Abeona Therapeutics, Inc

Related
2 trials

Shared therapeutic areas:

RDEBRecessive Dystrophic Epidermolysis Bullosa
Similarity Score20%

Jean Y Tang, PhD

Stanford University

Related
1 trials

Shared therapeutic areas:

Recessive Dystrophic Epidermolysis Bullosa
Similarity Score10%

Alain Hovnanian, Prof

National Institut of health and medical research

Related
1 trials

Shared therapeutic areas:

Recessive Dystrophic Epidermolysis Bullosa
Similarity Score10%

John A McGrath, FRCP

King's College London

Related
1 trials

Shared therapeutic areas:

Recessive Dystrophic Epidermolysis Bullosa
Similarity Score10%

Neda Nikbakht, MD, PhD

Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University

Related
1 trials

Shared therapeutic areas:

Recessive Dystrophic Epidermolysis Bullosa
Similarity Score10%

John McGrath, FRCP/FSci/MD

King's College London

Related
1 trials

Shared therapeutic areas:

Recessive Dystrophic Epidermolysis Bullosa
Similarity Score10%

Johann W. Bauer, MD

Paracelsus Medical University - EB House

Related
2 trials

Shared therapeutic areas:

Recessive Dystrophic Epidermolysis Bullosa
Similarity Score10%

David Woodley, MD

University of Southern California Department of Dermatology

Related
2 trials

Shared therapeutic areas:

Recessive Dystrophic Epidermolysis Bullosa
Similarity Score10%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT07193134Phase 1/2PrincipalInvestigator

GMEB-SASS: A Gene-Modified Skin Substitute for RDEB Treatment

Epidermolysis Bullosa Dystrophica, RecessiveRDEBRecessive Dystrophic Epidermolysis Bullosa
Recruiting

All 1 trials loaded